AMP0: Species-Specific Prediction of Anti-microbial Peptides using Zero
  and Few Shot Learning by Gull, Sadaf & Minhas, Fayyaz
X, YYYY, 0–0 
doi: X 
Advance Access Publication Date: DD Month YYYY 
Original Papers 
 
Machine learning 
AMP0: Species-Specific Prediction of Anti-
microbial Peptides using Zero and Few Shot 
Learning 
Sadaf Gull1 and Fayyaz Minhas2,* 
1,2 PIEAS Biomedical Informatics Lab, Pakistan Institute of Engineering and Applied Sciences, PO 
Nilore, Islamabad, Pakistan. 
2Department of Computer Science, University of Warwick, Coventry, UK 
1sadafzakarkhan@gmail.com, 2fayyaz.minhas14@alumni.colostate.edu 
*To whom correspondence should be addressed. 
Associate Editor: XXXXXXX 
Received on XXXXX; revised on XXXXX; accepted on XXXXX  
Abstract 
Motivation: The evolution of drug-resistant microbial species is one of the major challenges to global 
health. The development of new antimicrobial treatments such as antimicrobial peptides needs to be 
accelerated to combat this threat. However, the discovery of novel antimicrobial peptides is ham-
pered by low-throughput biochemical assays. Computational techniques can be used for rapid 
screening of promising antimicrobial peptide candidates prior to testing in the wet lab. The vast major-
ity of existing antimicrobial peptide predictors are non-targeted in nature, i.e., they can predict wheth-
er a given peptide sequence is antimicrobial, but they are unable to predict whether the sequence 
can target a particular microbial species. 
Results: In this work, we have developed a targeted antimicrobial peptide activity predictor that can 
predict whether a peptide is effective against a given microbial species or not. This has been made 
possible through zero-shot and few-shot machine learning. The proposed predictor called AMP0 
takes in the peptide amino acid sequence and any N/C-termini modifications together with the ge-
nomic sequence of a target microbial species to generate targeted predictions. It is important to note 
that the proposed method can generate predictions for species that are not part of its training set. The 
accuracy of predictions for novel test species can be further improved by providing a few example 
peptides for that species. Our computational cross-validation results show that the proposed scheme 
is particularly effective for targeted antimicrobial prediction in comparison to existing approaches and 
can be used for screening potential antimicrobial peptides in a targeted manner especially for cases 
in which the number of training examples is small. 
Availability: We have also developed a webserver of the proposed methodology available at 
http://ampzero.pythonanywhere.com. The data used for training and testing is also available for 
downloading, given in supplementary material. 
Contact: fayyaz.minhas14@alumni.colostate.edu  
Supplementary information: Supplementary data are available. 
 
1 Introduction  
Antibiotics play a significant role in protecting humans from microbial 
infections. The discovery and use of antibiotics since the 1930s has 
helped in treating serious infections and saved many lives (Aslam et al., 
2018).  (Blair, 2018; Ventola, 2015). Resistance against antibiotics in 
microbes was detected in the 1960s and it prompted an evolutionary 
arms race between microbes and antibiotics (Ventola, 2015). Antimicro-
bial resistance is currently a major global health crisis. The number of 
deaths due to infections caused by antibiotic resistance annually is in-
creasing and is estimated to reach up to 10 million by 2050 (Blair, 2018).  
Gull and Minhas 
Fig. 1. A general framework of machine learning predictors for (a) non targeted and (b) 
targeted predictions 
World Health Organization (WHO) has generated a list of antibiotic 
resistant bacterial species that are a major threat to global health and 
require urgent development of novel therapeutics against them: Entero-
coccus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Aci-
netobacter baumannii, Pseudomonas aeruginosa, and Enterobacter 
(Lakemeyer et al., 2018). 
To handle the issue of antibiotic resistance, the development of novel 
antibiotics is necessary (Aslam et al., 2018; Blair, 2018; Ventola, 2015; 
Lakemeyer et al., 2018; Spaulding et al., 2018). In comparison to the 
rate of development of antimicrobial resistance, the pace of discovery or 
development of new antibiotics is very slow: in the last 2 decades only 
two new classes of antibiotics were introduced for clinical use (Lake-
meyer et al., 2018). Consequently, the use of vaccines, lysins, antibodies, 
probiotics, bacteriophages and antimicrobial peptides (AMPs) is becom-
ing popular in therapeutics as alternatives to antibiotics (Aslam et al., 
2018). For designing new drugs, the use of AMPs is rapidly gaining 
attention (Aslam et al., 2018; Kampshoff et al., 2019; Costa et al., 2019; 
Yu et al., 2018). AMPs exhibit different biological activities against 
microbes, e.g., bacteria, viruses, fungi, etc. (Aslam et al., 2018), have 
higher inhibition rates than antibiotics, and can potentially slow down 
the evolution of antibiotic resistance as well (Yu et al., 2018).  
Potential AMP candidates need to be tested and evaluated experimental-
ly before entering clinical trials. The prediction of AMPs using machine 
learning techniques reduces the cost of identifying the effectiveness of a 
peptide sequence against microbial species in the wet lab by pre-
screening potential antimicrobial peptides. A number of machine learn-
ing based AMP predictors are available in the literature (Gull et al., 
2019; Bhadra et al., 2018; Torrent et al., 2009; Waghu et al., 2015; Lin 
and Xu, 2016; Agrawal and Raghava, 2018). The primary issue with 
these un-targeted predictors is that they are unable to predict whether a 
given peptide sequence will be effective against a given target microbial 
species or not (see Fig 1). Only a small number of targeted predictors 
exist in the literature but they are not able to generate predictions for 
novel microbial species (Kleandrova et al., 2016; Vishnepolsky et al., 
2018; Speck-Planche et al., 2016). Vishnepolsky et al. developed a pre-
dictor for 6 different gram-negative bacterial strains (Vishnepolsky et al., 
2018). The AMP predictor by Kleandrova et al. used 70 different gram-
negative strains of bacteria in training to predict antimicrobial and cyto-
toxic activity of individual amino acids in a peptide sequence for differ-
ent strains (Kleandrova et al., 2016). Although they covered a large set 
of bacterial species, their method can generate predictions for only spe-
cific strains of gram-negative bacterial strains. Unavailability of their 
predictor for public use is also a limitation (Kleandrova et al., 2016). The 
major drawback in targeted predictors is their inability of predicting a 
Table 1. Filtering criteria applied to DBAASP database to obtain 
required dataset 
Filtering criteria 
Number of 
peptides 
DBAASP monomer peptides 12,984 
Sequences with length >5 12,517 
Sequences with microbial targets (excluding cancers) 9,890 
Sequences with MIC in (𝜇𝑀) or (𝜇𝑔/𝑚𝐿) 8,045 
Sequences with target species genomes available in 
NCBI (Coordinators, 2016) 
8,025 
Sequences with at least one target species with MIC ≤
 25 𝜇𝑔/𝑚𝐿 
5,710 
peptide’s antimicrobial activity for novel microbial species. The predic-
tion of antimicrobial activity of a peptide without knowing the microbial 
species against which the peptide is effective is not meaningful.  
In this work, we have developed a machine learning model to over-
come this limitation. The proposed model takes amino acid sequence of a 
peptide and the genomic sequence of a target microbial species to predict 
the effectiveness of the peptide against that species in a targeted manner. 
2 Methods 
2.1. Data collection and preprocessing 
For constructing the dataset used for training and evaluation of our ma-
chine learning models, we have used DBAASP version 2 (Pirtskhalava et 
al., 2015). DBAASP has been widely used in recent studies in this field 
(Kleandrova et al., 2016; Youmans et al., 2017; Vishnepolsky et al., 
2018; Speck-Planche et al., 2016; Win et al., 2017). It contains a total of 
12, 984 peptide sequences and their experimentally verified minimum 
inhibitory concentrations (MICs) against various target microbial spe-
cies.  In order to construct our dataset from DBAASP, we have used 
peptides with length greater than 5 amino acids whose experimentally 
validated MICs are available in micro molar (𝜇𝑀) or microgram per 
milliliter (𝜇𝑔/𝑚𝐿). We also ensured that the genomes of the target spe-
cies are available in NCBI (Coordinators, 2016) and that each peptide in 
our dataset has at least one target species for which its MIC was ≤
 25 𝜇𝑔/𝑚𝐿 (Vishnepolsky et al., 2018). The details of different filtration 
stages to extract the dataset of our interest are given in Table-1. 
DBAASP reports the effectiveness of a peptide sequence against multi-
ple strains of a microbial species. We have taken the minimum MIC of a 
peptide across different strains of a species as its MIC against that spe-
cies. All MIC values have been converted to 𝜇𝑔/𝑚𝐿 (Kleandrova et al., 
2016). Our final dataset comprises of 5,710 peptides that are effective 
against a total of 336 different microbial species. The details of individu-
(a) 
 
(b) 
 
Fig 2. MICs converted to continuous labels between -1 to +1 using bipolar sigmoid 
function 
Species specific targeting of AMPs 
al peptides and their MICs against their target species is given in sup-
plementary material.  
As an additional preprocessing step, we have scaled the MIC scores 
using a sigmoidal curve such that MIC scores ≤ 25 𝜇𝑔/𝑚𝐿 are mapped 
onto +1 and those ≥ 100 𝜇𝑔/𝑚𝐿 are mapped to -1 (see Fig. 2). For this 
purpose, we have utilized a sigmoid rescaling function which maps raw 
MIC scores 𝑦 as follows:  
𝑦′ = 𝑠 (−
𝑦−55
10
) with   𝑠(𝑧) = 2 (
𝑒𝑧
1+𝑒𝑧
) − 1. 
This rescaling ensures that subsequent processing and machine learning 
models are not affected by large variations in MICs across different 
target species and peptides which can vary from a few 𝜇𝑔/𝑚𝐿 to more 
than 2000 𝜇𝑔/𝑚𝐿. If the MIC of a peptide is not known for a species, its 
rescaled score is set at 0.0. 
 
2.2. Feature extraction 
To predict antimicrobial activity of a peptide against given species 
through machine learning, we need features of peptide and genomic 
sequence of target microbial species as discussed below (see Fig. 3).  
2.2.1 Amino Acid Sequence features 
In order to obtain peptide-level features, we have used one-hot encod-
ing of the peptide sequence that results in a 40-dimensional feature vec-
tor (frequency count of 20 L-amino acids and 20 D-amino acids). The 
feature representation models the type of amino acid (L and D) in the 
peptide sequence separately as peptide bioactivity is dependent upon the 
type of amino acids (Cava et al., 2011; Mangoni et al., 2006; Baltz, 
2009; Kawai et al., 2004). The resulting feature vectors for a given pep-
tide is normalized to unit norm. We have also analyzed 2-mer composi-
tion which results in a 402 = 1600-dimensional feature vector (Leslie et 
al., 2001).  
DBAASP (Pirtskhalava et al., 2015) also provides information about N-
terminus and C-terminus modifications of peptides which can play a 
significant role in their antimicrobial activity. Modification at N-
terminus and C-terminus of peptides can change their biological activity 
(Crusca Jr et al., 2011). We have used one-hot encoding to capture in-
formation about C- and N-terminus modifications in our feature repre-
sentation. The sequence features are concatenated with C and N termini 
features. Details about the different types of C and N termini modifica-
tions are given in supplementary information. 
2.2.2 Genomic features 
In order to perform targeted prediction of antimicrobial activity of a 
peptide sequence against a particular species through machine learning, 
we need to extract species-level features as well. The literature reports 
the use of mono, di, tri and tetra-nucleotide composition of genomic 
sequences for comparison or clustering of genomes (Karlin and Ladunga, 
1994; Karlin et al., 1998; Kariin and Burge, 1995; Karlin, 1998; 
Nakashima et al., 1997, 1998; Pride et al., 2003; Takahashi et al., 2009). 
As a consequence, we have extracted features from complete genomes of 
species downloaded from NCBI (Coordinators, 2016). For feature ex-
traction the counts of 1-mer, 2-mer, 3-mer and 4-mer are calculated from 
a given genome sequence and normalized to unit norm resulting in a 
340-dimensional feature representation.  
2.3. Prediction Models 
 To predict whether a given peptide sequence will be effective against a 
target microbial species or not, we have proposed a zero-shot machine 
learning model. We compare the proposed model to a conventional ma 
 
 
chine learning model as a baseline as discussed below. In order to aid the 
reader in understanding our modeling approach for baseline and zero-
shot predictors, we denote a peptide sequence by its d-dimensional fea-
ture vector 𝒙𝒊, 𝑖 = 1, … , 5710 whereas a particular microbial species is 
represented by an a-dimensional attribute vector 𝒔𝒋, for 𝑗 = 1, … , 336 
based on its genomic sequence. We denote the rescaled MIC of a peptide 
𝒙𝒊 against species 𝒔𝒋 by the target variable 𝑦𝑖𝑗. The prediction problem 
can then be expressed as finding a mathematical function 𝑓(𝒙𝒊, 𝒔𝒋; 𝚯) 
parameterized by learnable parameters 𝚯 that can predict the effective-
ness of a sequence 𝒙𝒊 for microbial species 𝒔𝒋. 
2.3.1 Baseline models 
We have chosen Radial Basis Function SVM (Cortes and Vapnik, 1995) 
and XGBoost (Chen and Guestrin, 2016) as baseline models due to their 
widespread use and ease of modeling. For this purpose, in order to pre-
dict the effectiveness of a given peptide sequence against a microbial 
species, we construct a joint feature representation 𝝓𝒊𝒋 = [
𝒙𝒊
𝒔𝒋
] by concat-
enating peptide and species level features with the associated training 
label 𝑦𝑖𝑗 set to +1 (antimicrobial) if the MIC of peptide 𝒙𝒊 for species 𝒔𝒋 
is ≤ 25 𝜇𝑔/𝑚𝐿 and -1 (non-antimicrobial) if the MIC is ≥ 100 𝜇𝑔/𝑚𝐿. 
A conventional SVM or XGBoost model can then be trained over such a 
data set. 
2.3.2 Zero and Few shot learning 
 In this work, we propose to model the problem of targeted antimicro-
bial activity prediction through zero shot learning (ZSL) (Romera-
Paredes and Torr, 2015). Widely used in object classification and com-
puter vision, ZSL allows a classification model to generate predictions 
for novel classes which were not available at training time (Socher et al., 
2013; Norouzi et al., 2013; Fu et al., 2015). This is achieved by learning 
the definition of a class through an attribute vector representation instead 
of predicting class labels directly as in conventional classification. Many 
variants of ZSL have been proposed in the literature (Palatucci et al., 
2009; Zhang and Saligrama, 2015; Socher et al., 2013; Norouzi et al., 
2013; Fu et al., 2015; Kodirov et al., 2017; Romera-Paredes and Torr, 
2015). While ZSL assumes that no examples of a novel class presented 
during testing are available for training, the related case of few-shot 
learning aims at building a machine learning model such that only a few 
training examples are available for the target class (Snell et al., 2017; 
Sung et al., 2018; Gidaris and Komodakis, 2018; Garcia and Bruna, 
2017; Ravi and Larochelle, 2016). Few Shot Learning (FSL) techniques 
perform significantly better than conventional classification methods 
when the number of training examples is very small (Snell et al., 2017; 
Sung et al., 2018; Gidaris and Komodakis, 2018).  
The problem of targeted antimicrobial activity prediction is ideally 
suited to zero and few shot learning: in typical machine learning guided 
design of wet lab experiments for screening potential peptides that are 
effective against a target microbial species, no or very few peptides with 
known labels are available for training. Furthermore, in order to predict 
how effective a peptide is against a novel microbial species for which no 
or very few training examples are available, we can model the target 
Fig 3. Proposed model framework using features of peptide and genomic sequences 
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microbial species as a class represented by an attribute vector based on 
its genomic sequence. In this work, we have used the ZSL scheme given 
by Romera-Paredes and Torr (Romera-Paredes and Torr, 2015). For 
predicting the MIC of a peptide sequence for a target species, the dis-
criminant function used by the ZSL model of Romera-Paredes and Torr 
(Romera-Paredes and Torr, 2015) can be written as 𝑓(𝒙𝒊, 𝒔𝒋; 𝚯) =
𝒙𝑖
𝑇𝚯𝒔𝑗 with the learnable weight matrix 𝚯 ∈  ℝ
𝑑×𝑎. If the number of 
peptides and species (classes) available during training are 𝑚 and 𝑧, 
respectively and the rescaled MIC scores for each of the peptide against 
each microbe is represented by the 𝑚 × 𝑧 matrix 𝒀 ∈ [−1,1]𝑚×𝑧, the 
learning problem for ZSL can be formulated as the following optimiza-
tion problem: 
𝚯∗ =  ‖𝑿𝑻𝚯𝑺 − 𝒀‖𝑭𝒓𝒐
𝟐 + (
𝚯∈ℝ𝒅×𝒂
𝐚𝐫𝐠𝐦𝐢𝐧
𝜸‖𝚯𝑺‖𝑭
𝟐 + 𝝀‖𝑿𝑻𝚯‖𝑭
𝟐 +  𝜸𝝀‖𝚯‖𝑭
𝟐) 
Here, 𝑿 ∈  ℝ𝑑×𝑚 and 𝑺 ∈ ℝ𝑎×𝑧 represent matrices of all peptide fea-
tures (𝑚 examples each with a 𝑑-dimensional feature vector) and attrib-
utes of microbial species (𝑧 classes each with 𝑎 attributes), respectively. 
The first term represents the loss function with the aim of minimizing 
the error between predicted and target MICs. The second term 
(𝛾‖𝚯𝑺‖𝐹
2 + 𝜆‖𝑿𝑻𝚯‖𝐹
2 +  𝛾𝜆‖𝚯‖𝐹
2) is the regularization factor that en-
sures smoothness of the prediction function 𝑓(𝒙, 𝒔; 𝚯) and sparsity of the 
weight matrix 𝚯 through penalization of the Frobenius norm ‖∙‖𝐹
2  of 
respective matrices. 𝛾 and 𝜆 are regularization hyper-parameters. In 
addition to better performance over benchmark datasets, another reason 
for choosing this ZSL implementation is the existence of a computation-
ally efficient closed-form solution of its underlying optimization problem 
which can be written as follows:  
𝚯∗ = (𝑿𝑿𝑻 + 𝛾𝑰)−𝟏𝑿𝒀𝑺𝑻(𝑺𝑺𝑻 + 𝜆𝑰)−𝟏 
Once the optimal weight matrix 𝚯∗ has been obtained, the predictions 
for a peptide (represented by the feature vector 𝒙) for species (represent-
ed by the attribute vector 𝒔) can be generated by the decision function 
𝑓(𝒙, 𝒔; 𝚯∗) = 𝒙𝑻𝚯∗𝒔. Note that this decision function can be used for 
generating predictions both for novel peptides and novel species provid-
ed their attribute representation 𝒔 is available. The most likely target 
species for a given peptide can be identified by simply ranking the result-
ing decision function scores across a given list of potential target species.  
This formulation can be kernelized for non-linear kernels as well by 
applying the Representer theorem to the underlying optimization prob-
lem (Romera-Paredes and Torr, 2015). For this purpose, an 𝑚 × 𝑚 sized 
kernel matrix 𝑲 with 𝐾𝑖𝑗 = 𝑘(𝒙𝒊, 𝒙𝒋) is computed over the training data 
using a kernel function such as the radial basis function (RBF) 𝑘(𝒂, 𝒃) =
𝑒𝑥𝑝(−𝜅‖𝒂 − 𝒃‖2) with the hyperparameter 𝜅 > 0. The closed form 
solution of the kernelized ZSL optimization problem requires calculation 
of an 𝑚 × 𝑎 sized instance-attribute association matrix 𝚨 from training 
data as follows (see (Romera-Paredes and Torr, 2015) for details): 
𝚨 = (𝑲𝑻𝑲 + 𝜸𝑰)−𝟏𝑲𝒀𝑺(𝑺𝑻𝑺 + 𝝀𝑰)−𝟏 
For inference or prediction of effectiveness of a peptide represented 
by a feature vector 𝒙 against a microbial species represented by its at-
tribute vector 𝒔, an 𝑚-dimensional vector of kernel scores 𝒌(𝒙) =
[𝑘(𝒙, 𝒙𝟏) 𝑘(𝒙, 𝒙𝟐) ⋯ 𝑘(𝒙, 𝒙𝒎)]
𝑇 of the test example with each 
training example is computed and used in the kernelized prediction func-
tion 𝑓(𝒙, 𝒔; 𝑨) = 𝒌(𝒙)𝑻𝑨𝒔.  
It is important to note that this framework extends seamlessly to FSL 
by simply adding further training instances for a target class. The hy-
perparameters of the model (𝛾, 𝜆, 𝜅) are tuned through cross-validation.  
The best performance of the model was found using 𝛾 = 2.0, 𝜆 =
0.0001, and the hyperparameter 𝜅  of RBF kernel is set to 2.0.  
2.4. Performance evaluation 
We consider two practical use-cases of our system: 1) Target Species 
Ranking (TSR): given a set of microbial species for which labeled pep-
tide sequences are available for training, predict the microbe that is most-
likely to be targeted by a novel peptide sequence and, 2) Peptide Activity 
Prediction for Novel Species (PAP): predict whether a peptide is effec-
tive against a given species or not such that no or very few peptide ex-
amples for that species are available during training (i.e., Zero Shot or 
Few Shot Learning) (see Fig. 4). It is important to note that both these 
scenarios reflect practical use cases for biologists who are interested in 
machine-learning guided discovery for targeted antimicrobial peptides.  
In order to evaluate the performance of baseline and proposed machine 
learning models for TSR, we have used 5-fold cross validation (John Lu, 
2010). The dataset of 5,710 peptides is divided into 5 non-overlapping 
folds. A given model is trained on labeled examples of all peptides in 4 
folds and tested on the remaining peptides. This process is repeated 5 
times, once for each fold. For each test peptide in a fold, model scores 
for all 336 species are sorted in descending order. The rank of the highest 
scoring microbe that is a known target of the given test peptide (positive 
example) is used as a peptide-specific performance metric. This simple 
biologist-centric performance metric called Rank of First Positive Pre-
diction (RFPP) is based on the premise that an ideal machine learning 
model should assign high score to a known target species of a given 
peptide sequence and, consequently, rank target species at lower ranks in 
the sorted list in comparison to non-target species (Minhas et al., 2014). 
As a result, for an ideal machine learning model, the RFPP for all test 
peptides should be 1.0. As discussed in the results section, we report the 
percentile-wise RFPP scores for all test peptides for different machine 
learning models together with a random predictor as experimental con-
trol. The RFPP score at a certain percentile 𝑝, henceforth denoted by 
𝑅𝐹𝑃𝑃(𝑝) is defined as follows: 𝑅𝐹𝑃𝑃(𝑝)  =  𝑞, if 𝑝% test peptides have 
at least one known target microbial species among their top 𝑞 predictions 
(out of 336). Thus, for an ideal classifier 𝑅𝐹𝑃𝑃(100) = 1, i.e., for every  
(a) 
(b) 
Fig 4. (a) PAP takes inputs of a peptide sequence and a novel species genome to predict 
whether a peptide is effective against a given species or not; (b) TSR requires a novel 
peptide sequence and predicts the microbe that is most likely to be targeted by that pep-
tide (out of 336 given species) 
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peptide, the top scoring species is a real target species of the given test 
peptide. RFPP is a biologist-centric metric as it tells us directly how 
often top-ranking predictions of a peptide can be expected to correspond 
to true target species and it can be directly used in experiment design. 
For PAP, i.e., predicting a peptide’s effectiveness for a novel species, our 
proposed modeling approach takes peptide and genomic sequences as 
input and the score generated by the decision function of a machine 
learning model is used for classification of peptide sequences for indi-
vidual species. In order to quantify predictive accuracy, a selected set of 
17 test species from DBAASP with a small but sufficient number (75-
180) of known positive and negative peptide examples is used (details 
given in Table-2). For ZSL, the model is trained on all examples from 
other species and its predictive performance is evaluated for individual 
species in Table 2 using area under the receiver operating characteristic 
curve (AUC-ROC) as a performance metric (Davis and Goadrich, 2006). 
For few shots learning (FSL), a few positive and negative examples of a 
test species (1, 2, 4, 8 and half of all available examples for that species) 
are randomly sampled for training together with all examples from all 
other species and the model is evaluated on the remaining examples of 
the test species. This process is repeated 20 times with different species-
level training and test examples to get average AUC-ROC scores and 
their standard deviation. 
3 Results 
In this section, we discuss the results for the two learning tasks below. 
3.1 Target Species Ranking (TSR) 
Fig 5 shows the percentile-wise RFPP scores for all classifiers. As dis-
cussed in section 2.4, the ideal RFPP score for all peptides is 1.0. For the 
random classifier that generates a random score for a given example, the 
median RFPP is 75, i.e., for 50% test peptides in cross-validation, a true 
target species is within the top 75 (out of 336) predictions. In contrast, 
for XGBoost and SVM baseline models, the median RFPPs are 50 and 
10, respectively. However, the proposed model performs much better 
than these baseline models: the RFPP for the proposed model at the 75th 
percentile is 1.0, i.e., the for up to 75% peptides, the top prediction by 
the model is correct. This clearly shows the effectiveness of the proposed 
prediction scheme for identifying the correct target species of a peptide. 
For TSR use case optimal results of SVM and XGBoost were obtained 
with 2-mer composition features of peptides.  
 
3.2 Peptide Activity Prediction for Novel Species 
Table 2 shows the results of various machine learning models for the 
Peptide Activity Prediction (PAP) task. In this task the objective is to 
evaluate whether a given machine learning model can correctly predict 
peptides that target a novel species for which none or very few training 
examples are available. For this purpose, we compare the performance of 
conventional machine learning models (SVM, XGBoost), the proposed 
Zero Shot Learning (ZSL) and Few Shot Learning (FSL) models in 
addition to existing state of the art non-targeted antimicrobial activity 
predictors (CAMP (Waghu et al., 2015) (Gabere and Noble, 2017) and 
AMAP (Gull et al., 2019)). For this use case, XGBoost with amino acid 
composition features performed significantly better than SVM (results 
not shown for brevity). However, the prediction performance of 
XGBoost was typically no better than a random classifier especially 
when the number of training examples from a given test species was very 
small (see Supplementary Information for complete results). Similarly, 
existing state of the art methods such as CAMP (Waghu et al., 2015) and 
AMAP (Gull et al., 2019) do not give satisfactory predictive perfor-
mance for the chosen species. In contrast, the proposed few shot learning 
model performs significantly better than other methods with an expected 
increase in prediction accuracy when the number of training examples of 
a species is increased.  
3.3 Webserver and Code 
The webserver developed for proposed model together with the code is 
available at the URL:http://ampzero.pythonanywhere.com. The webserv-
er takes a peptide sequences in FASTA format along with any C-
terminus and N-terminus modifications as input together with the ge-
nome of a species in order to predict the degree of effectiveness of the 
peptide against the given species. Additionally, the user can upload a list 
of known positive and negative example peptide sequences for the given 
species for generating few shot learning based predictions.  
4 Conclusions  
We have developed a targeted antimicrobial activity predictor called 
AMPZero can predict the effectiveness of a given peptide sequence 
against a given target species. The use of zero and few shot learning in 
the proposed model helps in overcoming the shortcomings of conven-
tional machine learning techniques for this purpose. Our cross-validation 
analysis shows that the proposed model can perform better than existing 
approaches and it can be easily integrated in experimental discovery of 
antimicrobial peptide sequences for novel species.  
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Fig 5. Percentile-wise RFPP for target species ranking for various machine 
learning models 
Table 2 Results for Peptide Activity Prediction for Novel Species. The first column indicates the type of the different test species used in this analysis. 
The species name together with the total number of positive (P) and negative (N) examples available for that species are given in the second column. 
Results for zero shot learning (ZSL) in which no examples of the given test species are included in training are shown for the proposed ZSL model. For 
few shot learning results for different number of training examples (1, 2, 4, 8 and Half of all available examples) of the target species are shown. In the 
interest of relevance and brevity results for XGBoost are shown only when half of the available examples are used for training. CAMP and AMAP are 
existing state of the art predictors for antimicrobial activity and the prediction results were obtained using their respective webservers. Values in bold 
indicate the highest prediction performance. Note that the average AUC-ROC across multiple runs is reported together with the standard deviation (in 
parenthesis). 
Species 
Type 
Species Name ↓ 
 
No. of Tr. Examples → 
Machine Learning Models 
ZSL FSL XGBoost CAMP AMAP 
0 1 2 4 8 Half Half 
Fungus Aspergillus fumigatus 
(P: 44, N: 33) 
0.746 
(0.056) 
0.807 
(0.059) 
0.806 
(0.041) 
0.820 
(0.046) 
0.835 
(0.043) 
0.882 
(0.043) 
0.614 
(0.073) 
0.798 
(0.051) 
0.545 
(0.055) 
Candida glabrata 
(P35: , N:47 ) 
0.652 
(0.056) 
0.594 
(0.087) 
0.620 
(0.084) 
0.628 
(0.088) 
0.691 
(0.072) 
0.781 
(0.052) 
0.677 
(0.087) 
0.350 
(0.047) 
0.489 
(0.081) 
Candida parapsilosis 
(P:51 , N:33 ) 
0.430 
(0.088) 
0.473 
(0.094) 
0.507 
(0.106) 
0.562 
(0.093) 
0.663 
(0.089) 
0.789 
(0.055) 
0.639 
(0.120) 
0.660 
(0.069) 
0.662 
(0.075) 
Candida tropicalis 
(P:88 , N:16 ) 
0.755 
(0.078) 
0.712 
(0.072) 
0.735 
(0.076) 
0.771 
(0.078) 
0.803 
(0.071) 
0.865 
(0.042) 
0.669 
(0.066) 
0.703 
(0.076) 
0.561 
(0.058) 
Cryptococcus neoformans 
(P:167 , N:14 ) 
0.504 
(0.102) 
0.497 
(0.110) 
0.487 
(0.104) 
0.518 
(0.103) 
0.628 
(0.068) 
0.628 
(0.068) 
0.541 
(0.078) 
0.576 
(0.089) 
0.581 
(0.084) 
Saccharomyces cerevisiae 
(P:132 , N:36 ) 
0.405 
(0.061) 
0.627 
(0.064) 
0.634 
(0.060) 
0.650 
(0.064) 
0.681 
(0.072) 
0.788 
(0.052) 
0.604 
(0.046) 
0.388 
(0.053) 
0.448 
(0.043) 
Fusarium oxysporum 
(P:125 , N:18 ) 
0.856 
(0.045) 
0.914 
(0.040) 
0.919 
(0.043) 
0.932 
(0.038) 
0.943 
(0.033) 
0.961 
(0.021) 
0.696 
(0.094) 
0.418 
(0.049) 
0.396 
(0.033) 
Gram 
Negative 
Bacteria 
Enterobacter aerogenes 
(P:36 , N:49 ) 
0.468 
(0.061) 
0.588 
(0.084) 
0.599 
(0.063) 
0.646 
(0.088) 
0.731 
(0.078) 
0.826 
(0.051) 
0.773 
(0.069) 
0.550 
(0.067) 
0.443 
(0.069) 
Erwinia amylovora 
(P112: , N:35 ) 
0.478 
(0.059) 
0.385 
(0.062) 
0.450 
(0.068) 
0.543 
(0.069) 
0.714 
(0.069) 
0.892 
(0.047) 
0.907 
(0.032) 
0.877 
(0.021) 
0.385 
(0.046) 
Pasteurella multocida 
(P:37 , N:53 ) 
0.722 
(0.052) 
0.745 
(0.088) 
0.807 
(0.080) 
0.876 
(0.042) 
0.924 
(0.026) 
0.957 
(0.019) 
0.914 
(0.046) 
0.528 
(0.067) 
0.295 
(0.039) 
Proteus mirabilis 
(P:27 , N:105 ) 
0.714 
(0.052) 
0.729 
(0.045) 
0.733 
(0.047) 
0.748 
(0.054) 
0.767 
(0.045) 
0.836 
(0.048) 
0.731 
(0.079) 
0.377 
(0.046) 
0.269 
(0.065) 
Proteus vulgaris 
(P:84 , N:34 ) 
0.710 
(0.038) 
0.780 
(0.050) 
0.794 
(0.050) 
0.818 
(0.050) 
0.840 
(0.045) 
0.909 
(0.030) 
0.667 
(0.071) 
0.465 
(0.048) 
0.567 
(0.048) 
Serratia marcescens 
(P:48 , N:62 ) 
0.782 
(0.040) 
0.843 
(0.042) 
0.864 
(0.031) 
0.883 
(0.028) 
0.886 
(0.039) 
0.921 
(0.021) 
0.571 
(0.068) 
0.397 
(0.084) 
0.418 
(0.046) 
Gram 
Positive 
Bacteria 
Listeria innocua 
(P:64 , N:36 ) 
0.686 
(0.038) 
0.688 
(0.067) 
0.710 
(0.064) 
0.738 
(0.056) 
0.763 
(0.062) 
0.804 
(0.057) 
0.672 
(0.052) 
0.371 
(0.048) 
0.402 
(0.032) 
Streptococcus mutans 
(P:129 , N:11 ) 
0.437 
(0.119) 
0.570 
(0.118) 
0.597 
(0.116) 
0.616 
(0.136) 
0.825 
(0.045) 
0.825 
(0.045) 
0.767 
(0.108) 
0.472 
(0.099) 
0.706 
(0.083) 
Streptococcus pneumoniae 
(P:86 , N:17 ) 
0.591 
(0.077) 
0.619 
(0.090) 
0.609 
(0.089) 
0.622 
(0.079) 
0.623 
(0.077) 
0.701 
(0.066) 
0.507 
(0.071) 
0.3081 
(0.057) 
0.384 
(0.077) 
Streptococcus pyogenes 
(P:161 , N:09 ) 
0.660 
(0.050) 
0.733 
(0.044) 
0.737 
(0.044) 
0.747 
(0.053) 
0.873 
(0.037) 
0.873 
(0.037) 
0.669 
(0.069) 
0.569 
(0.156) 
0.737 
(0.062) 
References 
Afsar Minhas,F. ul A. et al. (2014) PAIRpred: Partner-specific prediction of inter-
acting residues from sequence and structure. Proteins: Structure, Function, and 
Bioinformatics, 82, 1142–1155. 
Agrawal,P. and Raghava,G.P. (2018) Prediction of Antimicrobial Potential of a 
Chemically Modified Peptide From Its Tertiary Structure. Frontiers in Microbi-
ology, 9, 2551. 
Aslam,B. et al. (2018) Antibiotic resistance: a rundown of a global crisis. Infection 
and drug resistance, 11, 1645. 
Baltz,R.H. (2009) Daptomycin: mechanisms of action and resistance, and biosyn-
thetic engineering. Current opinion in chemical biology, 13, 144–151. 
Bhadra,P. et al. (2018) AmPEP: Sequence-based prediction of antimicrobial pep-
tides using distribution patterns of amino acid properties and random forest. Sci-
entific reports, 8, 1697. 
Blair,J.M. (2018) A climate for antibiotic resistance. Nature Climate Change, 8, 
460. 
Cava,F. et al. (2011) Emerging knowledge of regulatory roles of D-amino acids in 
bacteria. Cellular and Molecular Life Sciences, 68, 817–831. 
Chen,T. and Guestrin,C. (2016) Xgboost: A scalable tree boosting system. In, 
Proceedings of the 22nd acm sigkdd international conference on knowledge dis-
covery and data mining. ACM, pp. 785–794. 
Species specific targeting of AMPs 
Coordinators,N.R. (2016) Database resources of the national center for biotechnol-
ogy information. Nucleic acids research, 44, D7. 
Cortes,C. and Vapnik,V. (1995) Support-vector networks. Machine learning, 20, 
273–297. 
Costa,F. et al. (2019) Clinical Application of AMPs. In, Antimicrobial Peptides. 
Springer, pp. 281–298. 
Crusca Jr,E. et al. (2011) Influence of N-terminus modifications on the biological 
activity, membrane interaction, and secondary structure of the antimicrobial 
peptide hylin-a1. Peptide Science, 96, 41–48. 
Davis,J. and Goadrich,M. (2006) The relationship between Precision-Recall and 
ROC curves. In, Proceedings of the 23rd international conference on Machine 
learning. ACM, pp. 233–240. 
Fu,Y. et al. (2015) Transductive multi-view zero-shot learning. IEEE transactions 
on pattern analysis and machine intelligence, 37, 2332–2345. 
Gabere,M.N. and Noble,W.S. (2017) Empirical comparison of web-based antimi-
crobial peptide prediction tools. Bioinformatics, 33, 1921–1929. 
Garcia,V. and Bruna,J. (2017) Few-shot learning with graph neural networks. arXiv 
preprint arXiv:1711.04043. 
Gidaris,S. and Komodakis,N. (2018) Dynamic few-shot visual learning without 
forgetting. In, Proceedings of the IEEE Conference on Computer Vision and 
Pattern Recognition., pp. 4367–4375. 
Gull,S. et al. (2019) AMAP: Hierarchical multi-label prediction of biologically 
active and antimicrobial peptides. Computers in biology and medicine, 107, 
172–181. 
John Lu,Z. (2010) The elements of statistical learning: data mining, inference, and 
prediction. Journal of the Royal Statistical Society: Series A (Statistics in Socie-
ty), 173, 693–694. 
Kampshoff,F. et al. (2019) A Pilot Study of the Synergy between Two Antimicro-
bial Peptides and Two Common Antibiotics. Antibiotics, 8, 60. 
Kariin,S. and Burge,C. (1995) Dinucleotide relative abundance extremes: a ge-
nomic signature. Trends in genetics, 11, 283–290. 
Karlin,S. et al. (1998) Comparative DNA analysis across diverse genomes. Annual 
review of genetics, 32, 185–225. 
Karlin,S. (1998) Global dinucleotide signatures and analysis of genomic heteroge-
neity. Current opinion in microbiology, 1, 598–610. 
Karlin,S. and Ladunga,I. (1994) Comparisons of eukaryotic genomic sequences. 
Proceedings of the National Academy of Sciences, 91, 12832–12836. 
Kawai,Y. et al. (2004) Structural and functional differences in two cyclic bacterioc-
ins with the same sequences produced by lactobacilli. Appl. Environ. Microbiol., 
70, 2906–2911. 
Kleandrova,V.V. et al. (2016) Enabling the discovery and virtual screening of 
potent and safe antimicrobial peptides. simultaneous prediction of antibacterial 
activity and cytotoxicity. ACS combinatorial science, 18, 490–498. 
Kodirov,E. et al. (2017) Semantic autoencoder for zero-shot learning. In, Proceed-
ings of the IEEE Conference on Computer Vision and Pattern Recognition., pp. 
3174–3183. 
Lakemeyer,M. et al. (2018) Thinking Outside the Box—Novel Antibacterials To 
Tackle the Resistance Crisis. Angewandte Chemie International Edition, 57, 
14440–14475. 
Leslie,C. et al. (2001) The spectrum kernel: A string kernel for SVM protein classi-
fication. In, Biocomputing 2002. World Scientific, pp. 564–575. 
Lin,W. and Xu,D. (2016) Imbalanced multi-label learning for identifying antimi-
crobial peptides and their functional types. Bioinformatics, 32, 3745–3752. 
Mangoni,M.L. et al. (2006) Effect of natural L-to D-amino acid conversion on the 
organization, membrane binding, and biological function of the antimicrobial 
peptides bombinins H. Biochemistry, 45, 4266–4276. 
Nakashima,H. et al. (1997) Di. erences in Dinucleotide Frequencies of Human, 
Yeast, and Escherichia coli Genes. DNA Research, 4, 185–192. 
Nakashima,H. et al. (1998) Genes from nine genomes are separated into their 
organisms in the dinucleotide composition space. DNA Research, 5, 251–259. 
Norouzi,M. et al. (2013) Zero-shot learning by convex combination of semantic 
embeddings. arXiv preprint arXiv:1312.5650. 
Palatucci,M. et al. (2009) Zero-shot learning with semantic output codes. In, Ad-
vances in neural information processing systems., pp. 1410–1418. 
Pirtskhalava,M. et al. (2015) DBAASP v. 2: an enhanced database of structure and 
antimicrobial/cytotoxic activity of natural and synthetic peptides. Nucleic acids 
research, 44, D1104–D1112. 
Pride,D.T. et al. (2003) Evolutionary implications of microbial genome tetranu-
cleotide frequency biases. Genome research, 13, 145–158. 
Ravi,S. and Larochelle,H. (2016) Optimization as a model for few-shot learning. 
Romera-Paredes,B. and Torr,P. (2015) An embarrassingly simple approach to zero-
shot learning. In, International Conference on Machine Learning., pp. 2152–
2161. 
Snell,J. et al. (2017) Prototypical networks for few-shot learning. In, Advances in 
Neural Information Processing Systems., pp. 4077–4087. 
Socher,R. et al. (2013) Zero-shot learning through cross-modal transfer. In, Ad-
vances in neural information processing systems., pp. 935–943. 
Spaulding,C.N. et al. (2018) Precision antimicrobial therapeutics: the path of least 
resistance? NPJ biofilms and microbiomes, 4, 4. 
Speck-Planche,A. et al. (2016) First multitarget chemo-Bioinformatic model to 
enable the discovery of antibacterial peptides against multiple gram-positive 
pathogens. Journal of chemical information and modeling, 56, 588–598. 
Sung,F. et al. (2018) Learning to compare: Relation network for few-shot learning. 
In, Proceedings of the IEEE Conference on Computer Vision and Pattern 
Recognition., pp. 1199–1208. 
Takahashi,M. et al. (2009) Estimation of bacterial species phylogeny through 
oligonucleotide frequency distances. Genomics, 93, 525–533. 
Torrent,M. et al. (2009) A theoretical approach to spot active regions in antimicro-
bial proteins. BMC bioinformatics, 10, 373. 
Ventola,C.L. (2015) The antibiotic resistance crisis: part 1: causes and threats. 
Pharmacy and therapeutics, 40, 277. 
Vishnepolsky,B. et al. (2018) Predictive Model of Linear Antimicrobial Peptides 
Active against Gram-Negative Bacteria. Journal of chemical information and 
modeling, 58, 1141–1151. 
Waghu,F.H. et al. (2015) CAMPR3: a database on sequences, structures and signa-
tures of antimicrobial peptides. Nucleic acids research, 44, D1094–D1097. 
Win,T.S. et al. (2017) HemoPred: a web server for predicting the hemolytic activi-
ty of peptides. Future medicinal chemistry, 9, 275–291. 
Youmans,M. et al. (2017) Long short-term memory recurrent neural networks for 
antibacterial peptide identification. In, 2017 IEEE International Conference on 
Bioinformatics and Biomedicine (BIBM). IEEE, pp. 498–502. 
Yu,G. et al. (2018) Predicting drug resistance evolution: insights from antimicrobi-
al peptides and antibiotics. Proceedings of the Royal Society B: Biological Sci-
ences, 285, 20172687. 
Zhang,Z. and Saligrama,V. (2015) Zero-shot learning via semantic similarity 
embedding. In, Proceedings of the IEEE international conference on computer 
vision., pp. 4166–4174. 
